2559
Physicians should therefore be aware of its occurrence and carefully monitor serum levels of CPK, GOT and GPT during the treatment of diabetes insipidus with clofibrate, especially in patients with associated hypothyroidism, latent or overt, which possibly favors the development of myopathy.
 ( adverse event: development ,  patients with associated hypothyroidism, latent or overt: Subject, hypothyroidism: Subject.Disorder, latent: Subject.Disorder, overt: Subject.Disorder, myopathy.: Effect, clofibrate: Treatment, diabetes insipidus: Treatment.Disorder, clofibrate: Treatment.Drug) 
Locate the role in the text that participated in the event based on the event type and return it in the event list. 
 Option: Event type: adverse event,potential therapeutic event, Arguments type: Treatment.Disorder,Treatment.Time_elapsed,Treatment.Dosage,Subject.Race,Treatment.Drug,Treatment.Route,Subject.Disorder,Treatment.Freq,Treatment,Effect,Subject.Population,Treatment.Duration,Combination.Drug,Subject,Subject.Age,Subject.Gender. 
Text: {0} 
Answer:
 ( adverse event: development ,  patients with associated hypothyroidism, latent or overt: Subject, hypothyroidism: Subject.Disorder, latent: Subject.Disorder, overt: Subject.Disorder, myopathy.: Effect, clofibrate: Treatment, diabetes insipidus: Treatment.Disorder, clofibrate: Treatment.Drug) 